Top compounds associated with response to KRAS


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.1 0.02
mRNA L-685458 CTRPv2 pan-cancer AAC 0.09 0.02
mRNA CGP-082996 GDSC1000 pan-cancer AAC 0.13 0.02
mRNA CP724714 GDSC1000 pan-cancer AAC 0.079 0.02
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.08 0.02
mRNA Bortezomib gCSI pan-cancer AAC -0.13 0.02
mRNA Rapamycin gCSI pan-cancer AAC 0.12 0.03
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.085 0.03
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.077 0.03
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.066 0.03
Download CSV